Clinical Trial Update: Effect of Add-on Citalopram to Risperidone on Negative Symptoms in Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating add-on citalopram to risperidone for improving negative symptoms in schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Citalopram (Citalopram hydrobromide)
• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: National Institute of Mental Health and Neuro Sciences, India | Conditions: Schizophrenia, Negative Symptoms | Phase 4 | Status: COMPLETED